Lixte Biotechnology Holdings Inc (LIXT)
2.882
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
2.89
+0.01
(+0.27%)
After-Hours: 20:00
Lixte Biotechnology Holdings Cash and Short Term Investments (Quarterly): 4.204M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.204M |
| September 30, 2023 | 5.106M |
| June 30, 2023 | 2.913M |
| March 31, 2023 | 4.088M |
| December 31, 2022 | 5.353M |
| September 30, 2022 | 6.562M |
| June 30, 2022 | 7.736M |
| March 31, 2022 | 3.778M |
| December 31, 2021 | 4.824M |
| September 30, 2021 | 5.961M |
| June 30, 2021 | 6.798M |
| March 31, 2021 | 7.739M |
| December 31, 2020 | 5.069M |
| September 30, 2020 | 1.076M |
| June 30, 2020 | 1.774M |
| March 31, 2020 | 2.185M |
| December 31, 2019 | 2.599M |
| September 30, 2019 | 2.976M |
| June 30, 2019 | 3.564M |
| March 31, 2019 | 3.894M |
| December 31, 2018 | 4.273M |
| September 30, 2018 | 0.3744M |
| June 30, 2018 | 0.536M |
| March 31, 2018 | 0.808M |
| December 31, 2017 | 1.306M |
| Date | Value |
|---|---|
| September 30, 2017 | 1.590M |
| June 30, 2017 | 2.032M |
| March 31, 2017 | 0.8709M |
| December 31, 2016 | 0.1999M |
| September 30, 2016 | 0.6698M |
| June 30, 2016 | 1.150M |
| March 31, 2016 | 0.9702M |
| December 31, 2015 | 0.1294M |
| September 30, 2015 | 0.7416M |
| June 30, 2015 | 1.251M |
| March 31, 2015 | 1.457M |
| December 31, 2014 | 0.2581M |
| September 30, 2014 | 0.9026M |
| June 30, 2014 | 1.240M |
| March 31, 2014 | 0.1216M |
| December 31, 2013 | 0.4812M |
| September 30, 2013 | 0.7971M |
| June 30, 2013 | 1.082M |
| March 31, 2013 | 1.381M |
| December 31, 2012 | 1.661M |
| September 30, 2012 | 1.887M |
| June 30, 2012 | 2.183M |
| March 31, 2012 | 0.1498M |
| December 31, 2011 | 0.3654M |
| September 30, 2011 | 0.9311M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
1.076M
Minimum
Sep 2020
7.739M
Maximum
Mar 2021
4.437M
Average
4.204M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| iBio Inc | 2.788M |
| PAVmed Inc | 19.64M |
| PDS Biotechnology Corp | 56.56M |
| Moleculin Biotech Inc | 23.55M |
| Syros Pharmaceuticals Inc | 139.53M |